Kanabo Group (LON:KNB) Sets New 1-Year Low – Should You Sell?

Shares of Kanabo Group Plc (LON:KNB) hit a new 52-week low during trading on Monday . The company traded as low as GBX 0.90 ($0.01) and last traded at GBX 1 ($0.01), with a volume of 275477 shares trading hands. The stock had previously closed at GBX 1.10 ($0.01).

Kanabo Group Trading Down 9.1 %

The business’s 50-day moving average is GBX 1.08 and its two-hundred day moving average is GBX 1.30. The company has a current ratio of 2.78, a quick ratio of 24.36 and a debt-to-equity ratio of 3.49. The stock has a market capitalization of £6.32 million, a PE ratio of -100.00 and a beta of 3.04.

Insider Activity

In related news, insider Ian Mattioli bought 150,000 shares of the company’s stock in a transaction dated Tuesday, August 27th. The stock was bought at an average price of GBX 1 ($0.01) per share, with a total value of £1,500 ($1,883.95). Insiders own 37.01% of the company’s stock.

Kanabo Group Company Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.